Company intelligence / Profile preview

Sterkem Pharma

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Sterkem Pharma has a commercial portfolio of generic and branded small molecule drugs in pain management, infection, gynecology, psychiatry, and supplements[2][3]. No clinical trial results or proprietary clinical-stage compounds found.

Therapeutic areas: HematologyImmunologyWomen's HealthNeurologyInfectious DiseasesRheumatologyPsychiatryOncology
Modalities: Small moleculeEnzyme (e.g., protease)AntibioticNutritional supplement
Industry: Biotech

Beyond the preview

Go deeper on Sterkem Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterkem Pharma.

Explore the full profile